354 related articles for article (PubMed ID: 23821509)
21. Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection.
Vos R; Vanaudenaerde BM; Verleden SE; Ruttens D; Vaneylen A; Van Raemdonck DE; Dupont LJ; Verleden GM
Transplantation; 2012 Jul; 94(2):101-9. PubMed ID: 22461039
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction.
Levy L; Moshkelgosha S; Huszti E; Hunter S; Renaud-Picard B; Berra G; Kawashima M; Fernandez-Castillo J; Fuchs E; Dianti M; Ghany R; Keshavjee S; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2023 Aug; 42(8):1152-1160. PubMed ID: 36963446
[TBL] [Abstract][Full Text] [Related]
23. Restrictive chronic lung allograft dysfunction: Where are we now?
Verleden SE; Ruttens D; Vandermeulen E; Bellon H; Van Raemdonck DE; Dupont LJ; Vanaudenaerde BM; Verleden G; Vos R
J Heart Lung Transplant; 2015 May; 34(5):625-30. PubMed ID: 25577564
[TBL] [Abstract][Full Text] [Related]
24. Chronic lung allograft dysfunction after lung transplantation: the moving target.
Sato M
Gen Thorac Cardiovasc Surg; 2013 Feb; 61(2):67-78. PubMed ID: 23138970
[TBL] [Abstract][Full Text] [Related]
25. Chronic lung allograft dysfunction phenotype and prognosis by machine learning CT analysis.
McInnis MC; Ma J; Karur GR; Houbois C; Levy L; Havlin J; Fuchs E; Tikkanen J; Chow CW; Huszti E; Martinu T
Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34949699
[TBL] [Abstract][Full Text] [Related]
26. Functional and computed tomographic evolution and survival of restrictive allograft syndrome after lung transplantation.
Verleden SE; de Jong PA; Ruttens D; Vandermeulen E; van Raemdonck DE; Verschakelen J; Vanaudenaerde BM; Verleden GM; Vos R
J Heart Lung Transplant; 2014 Mar; 33(3):270-7. PubMed ID: 24461432
[TBL] [Abstract][Full Text] [Related]
27. Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients.
Greer M; Dierich M; De Wall C; Suhling H; Rademacher J; Welte T; Haverich A; Warnecke G; Ivanyi P; Buchholz S; Gottlieb J; Fuehner T
Am J Transplant; 2013 Apr; 13(4):911-918. PubMed ID: 23406373
[TBL] [Abstract][Full Text] [Related]
28. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy.
Vanaudenaerde BM; Meyts I; Vos R; Geudens N; De Wever W; Verbeken EK; Van Raemdonck DE; Dupont LJ; Verleden GM
Eur Respir J; 2008 Oct; 32(4):832-43. PubMed ID: 18827151
[TBL] [Abstract][Full Text] [Related]
29. CT at onset of chronic lung allograft dysfunction in lung transplant patients predicts development of the restrictive phenotype and survival.
Dettmer S; Shin HO; Vogel-Claussen J; Westphal M; Haverich A; Warnecke G; Welte T; Wacker F; Gottlieb J; Suhling H
Eur J Radiol; 2017 Sep; 94():78-84. PubMed ID: 28647206
[TBL] [Abstract][Full Text] [Related]
30. High-Resolution CT Findings of Obstructive and Restrictive Phenotypes of Chronic Lung Allograft Dysfunction: More Than Just Bronchiolitis Obliterans Syndrome.
Hota P; Dass C; Kumaran M; Simpson S
AJR Am J Roentgenol; 2018 Jul; 211(1):W13-W21. PubMed ID: 29792746
[TBL] [Abstract][Full Text] [Related]
31. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
Benden C; Haughton M; Leonard S; Huber LC
J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
[TBL] [Abstract][Full Text] [Related]
32. Managing bronchiolitis obliterans syndrome (BOS) and chronic lung allograft dysfunction (CLAD) in children: what does the future hold?
Snell GI; Paraskeva M; Westall GP
Paediatr Drugs; 2013 Aug; 15(4):281-9. PubMed ID: 23605986
[TBL] [Abstract][Full Text] [Related]
33. Restrictive allograft dysfunction rather than bronchiolitis obliterans syndrome had a major impact on the overall survival after living-donor lobar lung transplantation.
Matsubara K; Otani S; Yamamoto H; Hashimoto K; Tanaka S; Shien K; Suzawa K; Miyoshi K; Yamamoto H; Okazaki M; Sugimoto S; Toyooka S
Surg Today; 2024 Apr; 54(4):317-324. PubMed ID: 37523071
[TBL] [Abstract][Full Text] [Related]
34. Chronic Lung Allograft Dysfunction.
Venado A; Kukreja J; Greenland JR
Thorac Surg Clin; 2022 May; 32(2):231-242. PubMed ID: 35512941
[TBL] [Abstract][Full Text] [Related]
35. Phenotyping Chronic Lung Allograft Dysfunction Using Body Plethysmography and Computed Tomography.
Suhling H; Dettmer S; Greer M; Fuehner T; Avsar M; Haverich A; Welte T; Gottlieb J
Am J Transplant; 2016 Nov; 16(11):3163-3170. PubMed ID: 27203799
[TBL] [Abstract][Full Text] [Related]
36. Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?
Verleden GM; Dupont LJ; Van Raemdonck DE
Eur Respir J; 2005 Feb; 25(2):221-4. PubMed ID: 15684284
[TBL] [Abstract][Full Text] [Related]
37. Role of 18F-FDG PET/CT in Restrictive Allograft Syndrome After Lung Transplantation.
Verleden SE; Gheysens O; Goffin KE; Vanaudenaerde BM; Verbeken EK; Weynand B; Van Raemdonck DE; Verleden GM; Vos R
Transplantation; 2019 Apr; 103(4):823-831. PubMed ID: 30086092
[TBL] [Abstract][Full Text] [Related]
38. Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction.
Todd JL; Jain R; Pavlisko EN; Finlen Copeland CA; Reynolds JM; Snyder LD; Palmer SM
Am J Respir Crit Care Med; 2014 Jan; 189(2):159-66. PubMed ID: 24325429
[TBL] [Abstract][Full Text] [Related]
39. Long-Term Off-Line Extracorporeal Photochemotherapy in Patients with Chronic Lung Allograft Rejection Not Responsive to Conventional Treatment: A 10-Year Single-Centre Analysis.
Del Fante C; Scudeller L; Oggionni T; Viarengo G; Cemmi F; Morosini M; Cascina A; Meloni F; Perotti C
Respiration; 2015; 90(2):118-28. PubMed ID: 26112178
[TBL] [Abstract][Full Text] [Related]
40. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]